CMC strategy
Clear development plans connecting science, regulation, cost and timelines.
Vaccine & biopharma development
Turning complex science into manufacturable medicines.
Senior CMC leadership and hands-on technical expertise to move vaccines and biologics from development strategy to clinical manufacture.
Start a conversation ↗
UK-based
Supporting global programmes
Science→Impact
Strategy
Scale-up
Clinical supply
How we help
Expert support where it matters most.
Process & scale-up
Hands-on support across process, analytics, formulation and clinical manufacture.
Technology transfer
CDMO selection, transfer leadership and rapid resolution of manufacturing issues.
20+years in vaccines
and biopharma
and biopharma
10+products progressed
towards market
towards market
Globalregulatory and
CDMO experience
CDMO experience
Viral vectors · Proteins & VLPs · Live & inactivated vaccines · mRNA